text_1: 此外 , abemaciclib + 氟维司 群 显著 延长 了 OS ( 46.7 个 月 vs . 37.3 个 月 ; P = 0.0137 ) , 并 显著 推迟 了 后续 化疗 的 时间 .
  
text_2: in addition , abemaciclib plus fulvestrant significantly improved OS ( 46.7 vs. 37.3 months ; P = 0.0137 ) and significantly delayed the time to subsequent chemotherapy .
  